These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2691956)

  • 1. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
    Gai XX; Rizzo MG; Valpreda S; Baserga R
    Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ; Pledger WJ
    J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
    Kirstein M; Baglioni C
    J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes.
    Gai XX; Rizzo MG; Lee J; Ullrich A; Baserga R
    Oncogene Res; 1988; 3(4):377-86. PubMed ID: 3067189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
    Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
    Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism.
    Reiss K; Ferber A; Travali S; Porcu P; Phillips PD; Baserga R
    Cancer Res; 1991 Nov; 51(21):5997-6000. PubMed ID: 1657376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors.
    Pietrzkowski Z; Lammers R; Carpenter G; Soderquist AM; Limardo M; Phillips PD; Ullrich A; Baserga R
    Cell Growth Differ; 1992 Apr; 3(4):199-205. PubMed ID: 1325181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD; Scott JK; Watt RA; Astrin SM
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
    Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
    Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53.
    Chenevix-Trench G; Martin NG; Ellem KA
    Oncogene; 1990 Aug; 5(8):1187-93. PubMed ID: 1697409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
    Charollais RH; Mester J
    J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation.
    Conover CA; Bale LK
    Exp Cell Res; 1998 Jan; 238(1):122-7. PubMed ID: 9457064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factors and proto-oncogenes in early mouse embryogenesis and tumorigenesis.
    Pavelić K; Pecina Slaus N; Spaventi R
    Int J Dev Biol; 1991 Sep; 35(3):209-14. PubMed ID: 1814404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
    Pape KA; Floyd-Smith G
    Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.